ClinicalTrials.gg
CompletedNCT03880461Updated Jul 29, 2026Results posted

A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

An interventional study of Lifestyle Intervention in Gestational Weight Gain, sponsored by Kaiser Permanente. Completed at 4 sites in United States. Open to female participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by Kaiser Permanente · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,335
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
Female
01

Study summary

The aim of this trial is to investigate the effectiveness of a mobile health (mhealth) intervention to help overweight and obese women achieve appropriate gestational weight gain (GWG) for their pre-pregnancy body mass index (BMI). The goal of the intervention is to help women achieve GWG within the range recommended by the Institute of Medicine. The investigators propose an adaptive intervention that begins with an effective, yet low resource-intensive treatment and then provides incremental support and resources only to patients who need them. The intervention includes: 1) an mHealth tool allowing data to be automatically transmitted to a mobile website; 2) personalized text messages; and 3) personalized 1:1 telephone coaching sessions. The latter more intensive components are reserved for patients whose GWG is not within the IOM guidelines. The lifestyle intervention will be delivered through 1 telephone counseling session with a study dietician trained in motivational interviewing techniques, as well as through technology-based tools, automated text messages and weekly e-mails of core lifestyle intervention sessions. Personalized text messages and 1:1 telephone coaching sessions will be given to those who are not meeting the GWG guidelines. The lifestyle intervention will be compared to usual medical care. Maternal outcomes will be assessed shortly before delivery and at 6 weeks postpartum. Infant birthweight and weight at one year will also be assessed.

02

Conditions studied

  • Gestational Weight Gain

Keywords

  • Gestational weight gain
  • Lifestyle
  • Intervention
  • Body weight
  • Overweight
  • Obesity
  • Signs and Symptoms
  • Body weight changes
03

In context

Gestational Weight Gain

134 studies on the registry are indexed under Gestational Weight Gain; 24 are open to participants now.

This study's enrollment of 1,335 is above the median of 104 across 108 interventional studies indexed under Gestational Weight Gain.

Browse Gestational Weight Gain studies →

Lead sponsor

Kaiser Permanente is the lead sponsor of 393 studies on the registry; 43 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 3 (43%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant
  • Women receiving prenatal care at Kaiser Permanente San Francisco and Oakland and whose obstetric care clinicians consent to participate;
  • Pregravid 25 to \<40 (as determined from a measured pregravid weight in electronic medical record);
  • Has access to a smartphone and Wi-Fi;
  • Provides to participate.

Exclusion criteria

Exclusion Criteria:

  • Multiple births;
  • Planning to move out of the area during the study period;
  • Inability to speak, read, or understand English;
  • Placed on bed rest at time of enrollment; ->15 weeks' gestation at enrollment.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,335 participants (actual)

Study arms

  • Experimental
    Lifestyle Intervention

    The goal of the intervention is to help women achieve GWG within the range recommended by the Institute of Medicine. The lifestyle intervention will be delivered through 1 telephone counseling session with a study dietician trained in motivational interviewing techniques, as well as through technology-based tools, automated text messages and weekly e-mails of core lifestyle intervention sessions. Personalized text messages and 1:1 telephone coaching sessions will be given to those who are not meeting the GWG guidelines.

    Behavioral: Lifestyle Intervention

  • No intervention
    Usual Care - Control

    Usual Medical Care

Interventions

  • BehavioralLifestyle Intervention

    Behavioral lifestyle intervention

06

What researchers measure

Primary outcomes

  1. Total Gestational Weight Gain (GWG)

    Calculated as last measured pregnancy weight at the time of delivery minus measured weight at 10 gestational weeks

    Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

  2. Rate of Total GWG

    Calculated as total gestational weight gain / (# of weeks between 10 gestational weeks and the time of delivery)

    Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

  3. Proportion of Women Meeting the Institute of Medicine's GWG Recommendation

    Proportion of women meeting the IOM's GWG recommendation for weekly rate of GWG

    Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

Secondary outcomes

  1. Trimester-specific Weekly Rate of GWG

    Time frame: 0 - 13 gestational weeks; 14 - 26 gestational weeks; 27 - 40 gestational weeks

  2. GWG Trajectory Throughout Pregnancy

    Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

  3. Change in Moderate to Vigorous Physical Activity (in MET Hrs/Week) as Assessed by the Pregnancy Physical Activity Questionnaire (PPAQ)

    We will assess change in moderate to vigorous physical activity between study assessments in pregnancy. The sports and exercise domain encompasses 10 PPAQ activities of moderate intensity (ranging 3.2 MET to 6 MET) and 2 PPAQ activities of vigorous intensity (6.5 MET and 7 MET). The volumes of all activities in the sports and exercise domain will be summed to arrive at an estimate of overall volume of moderate to vigorous intensity sports and exercise activity, expressed in MET hours per week. Higher levels of activity are generally associated with better outcomes. The distributions of all physical activity variables will be assessed for outliers.

    Time frame: Between 12 weeks and 33 weeks of pregnancy

  4. Overall Diet Quality According to the Healthy Eating Index-2015 (HEI-2015)

    The HEI-2015 reflects adherence to the 2015-2020 Dietary Guidelines for Americans; it is comprised of 13 components as well as an overall score. The scoring system ranges from 0 to 100, where higher values indicate a better diet quality.

    Time frame: Assessed at 12 weeks of pregnancy

  5. Postpartum Weight Retention

    Time frame: Assessed at 6 weeks postpartum

  6. The Proportion of Infants With Appropriate Birthweight (>10th and <90th Percentile of Sex-, Gestational Age-, and Racial/Ethnic-specific Distribution)

    Time frame: Assessed at birth

  7. Infant Growth (BMI Z-score)

    Time frame: From birth to 12 months of age

07

Results

Posted Apr 18, 2025

Participant flow

Participant flow — Overall Study
MilestoneIntervention Arm - PATIENTSUsual Care Arm - PATIENTS
Started714621
Completed645560
Not completed6961
Withdrew: Determined ineligible after enrollment4544
Withdrew: No weight measurement after enrollment2417

Outcome measures

PrimaryTotal Gestational Weight Gain (GWG)

Calculated as last measured pregnancy weight at the time of delivery minus measured weight at 10 gestational weeks

Time frame:
From 10 gestational weeks until time of delivery (duration of up to 9 months)
Reported as:
Mean · kilograms
Total Gestational Weight Gain (GWG)
kilogramsIntervention Arm - PATIENTSUsual Care Arm - PATIENTS
Total Gestational Weight Gain (GWG)10.5 ± 5.711.3 ± 5.9
Statistical analysis
  • Intervention Arm - PATIENTS vs Usual Care Arm - PATIENTS · t-test, 2 sided · p = 0.014
PrimaryRate of Total GWG

Calculated as total gestational weight gain / (# of weeks between 10 gestational weeks and the time of delivery)

Time frame:
From 10 gestational weeks until time of delivery (duration of up to 9 months)
Reported as:
Mean · kilograms/week
Rate of Total GWG
kilograms/weekIntervention Arm - PATIENTSUsual Care Arm - PATIENTS
Rate of Total GWG0.26 ± 0.170.28 ± 0.16
Statistical analysis
  • Intervention Arm - PATIENTS vs Usual Care Arm - PATIENTS · t-test, 2 sided · p = 0.003
PrimaryProportion of Women Meeting the Institute of Medicine's GWG Recommendation

Proportion of women meeting the IOM's GWG recommendation for weekly rate of GWG

Time frame:
From 10 gestational weeks until time of delivery (duration of up to 9 months)
Reported as:
Count of participants · Participants
Proportion of Women Meeting the Institute of Medicine's GWG Recommendation
ParticipantsIntervention Arm - PATIENTSUsual Care Arm - PATIENTS
Proportion of Women Meeting the Institute of Medicine's GWG Recommendation172126
Statistical analysis
  • Intervention Arm - PATIENTS vs Usual Care Arm - PATIENTS · ANOVA · p = 0.108
SecondaryTrimester-specific Weekly Rate of GWG
Time frame:
0 - 13 gestational weeks; 14 - 26 gestational weeks; 27 - 40 gestational weeks

Results for this outcome have not been posted.

SecondaryGWG Trajectory Throughout Pregnancy
Time frame:
From 10 gestational weeks until time of delivery (duration of up to 9 months)

Results for this outcome have not been posted.

SecondaryChange in Moderate to Vigorous Physical Activity (in MET Hrs/Week) as Assessed by the Pregnancy Physical Activity Questionnaire (PPAQ)

We will assess change in moderate to vigorous physical activity between study assessments in pregnancy. The sports and exercise domain encompasses 10 PPAQ activities of moderate intensity (ranging 3.2 MET to 6 MET) and 2 PPAQ activities of vigorous intensity (6.5 MET and 7 MET). The volumes of all activities in the sports and exercise domain will be summed to arrive at an estimate of overall volume of moderate to vigorous intensity sports and exercise activity, expressed in MET hours per week. Higher levels of activity are generally associated with better outcomes. The distributions of all physical activity variables will be assessed for outliers.

Time frame:
Between 12 weeks and 33 weeks of pregnancy

Results for this outcome have not been posted.

SecondaryOverall Diet Quality According to the Healthy Eating Index-2015 (HEI-2015)

The HEI-2015 reflects adherence to the 2015-2020 Dietary Guidelines for Americans; it is comprised of 13 components as well as an overall score. The scoring system ranges from 0 to 100, where higher values indicate a better diet quality.

Time frame:
Assessed at 12 weeks of pregnancy

Results for this outcome have not been posted.

SecondaryPostpartum Weight Retention
Time frame:
Assessed at 6 weeks postpartum

Results for this outcome have not been posted.

SecondaryThe Proportion of Infants With Appropriate Birthweight (>10th and <90th Percentile of Sex-, Gestational Age-, and Racial/Ethnic-specific Distribution)
Time frame:
Assessed at birth

Results for this outcome have not been posted.

SecondaryInfant Growth (BMI Z-score)
Time frame:
From birth to 12 months of age

Results for this outcome have not been posted.

Adverse events

Collected over Adverse outcome data were collected during pregnancy from enrollment to delivery (duration of up to 9 months).. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Arm - PATIENTS0/714 (0%)0/714 (0%)44/714 (6.2%)
Usual Care Arm - PATIENTS0/621 (0%)0/621 (0%)29/621 (4.7%)
Most frequent other events
Most frequent other events
EventIntervention Arm - PATIENTSUsual Care Arm - PATIENTS
Total pregnancy loss or stillbirthPregnancy, puerperium and perinatal conditions44/71429/621

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Mean33.3 ± 4.733.4 ± 4.533.4 ± 4.6
Age, Customized
Age, Customized(Participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Age (years) — 21 - 29158122280
Age (years) — 30 - 34259238497
Age (years) — 35 - 39234215449
Age (years) — 40 - 466346109
Sex: Female, Male
Sex: Female, Male(Participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Female7146211335
Male000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Race / Ethnicity — Non-Hispanic White237211448
Race / Ethnicity — Black414081
Race / Ethnicity — Asian / Pacific Islander175137312
Race / Ethnicity — Hispanic186165351
Race / Ethnicity — Native American10414
Race / Ethnicity — Islander6410
Race / Ethnicity — Multiracial374178
Race / Ethnicity — Unknown / Missing221941
Region of Enrollment
Region of Enrollment(participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
United States7146211335
Pre-pregnancy BMI (Continuous)
Pre-pregnancy BMI (Continuous)(kg/m2)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Mean29.7 ± 3.830.0 ± 3.929.8 ± 3.8
Pre-pregnancy BMI (Customized)
Pre-pregnancy BMI (Customized)(Participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Overweight (25.0 - 29.9)430354784
Obese (30.0 - 39.9)284267551
Parity (Customized)
Parity (Customized)(Participants)Intervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Nulliparous319238557
Primiparous270239509
Multiparous103127230
Unknown / Missing221739
08

Study locations

4 sites
  • Kaiser Permanente Oakland
    Oakland, California 94612, United States
  • Kaiser Permanente Redwood City
    Redwood City, California 94063, United States
  • Kaiser Permanente San Francisco
    San Francisco, California 94115, United States
  • Kaiser Permanente Santa Clara
    Santa Clara, California 95051, United States
09

References and documents

Publications

  • Sridhar SB, Ferrara A, Brown SD, Quesenberry CP, Xu F, Liu E, Sedgwick T, Kissel P, Serrato Bandera HD, Albright C, Hedderson MM. Protocol of an adaptive mobile health intervention for the management of gestational weight gain: The LEAP cluster randomized controlled trial. Contemp Clin Trials. 2025 Feb;149:107781. doi: 10.1016/j.cct.2024.107781. Epub 2024 Dec 20. PubMed 39710337 ↗
  • Hedderson MM, Brown SD, Quesenberry CP, Xu F, Liu EF, Li KL, Sridhar SB, Sedgwick T, Kissel P, Bandera HDS, Bhalala MM, Albright CL, Ferrara A. Adaptive Mobile Health Intervention to Reduce Excess Gestational Weight Gain: A Cluster-Randomized Clinical Trial. JAMA Netw Open. 2026 Apr 1;9(4):e268007. doi: 10.1001/jamanetworkopen.2026.8007. PubMed 42008264 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Mar 2024, 38 months.

Results were first posted in Apr 2025, 1 year after primary completion.

Of 84 non-industry interventional studies with no phase under Gestational Weight Gain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 38. This study's 38 months is above that.

Counting every sponsor, half of 84 studies reached it within 24 months; a quarter within 13 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2019
First posted
Mar 19, 2019
StartActual
Jan 21, 2021
Primary completionActual
Mar 28, 2024
CompletionActual
Mar 31, 2025
Results first posted
Apr 18, 2025
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03880461
Lead sponsor
Kaiser Permanente
Responsible party
Sponsor
First posted
Mar 19, 2019
Start date
Jan 21, 2021
Primary completion
Mar 28, 2024
Completion
Mar 31, 2025
Results posted
Apr 18, 2025
Last update
Jul 29, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion